Will the Bristol-Myers Decision of Personal Jurisdiction Further Consolidate Litigation in MDLs?

We were able to obtain a verdict for Mr. Cooper within a year of opting for the state courts.

Bristol-Myers MDLs

Jeffrey Travers and Michael J. Miller

October 12, 2017 09:43 AM

When Jack Cooper developed metastatic bladder cancer after taking the medication Actos, I had to make the choice of joining a federal MDL proceeding against Takeda Pharmaceuticals or pursuing his case and others like his in state courts. I chose to pursue the cases in state courts because, as one federal judge stated, “MDL practice is slow—very slow.”[1] Slow wasn’t going to work for these clients, and I was confident that with increased productivity from advances in technology, our firm could handle this major mass tort case without assistance from the multiple firms in the MDL proceedings.

We were able to obtain a verdict for Mr. Cooper within a year of opting for the state courts.

We subsequently tried five more cases in various state courts over the next two years, obtaining four more plaintiff verdicts and settling the remainder.

Just as technology has helped even the playing field between plaintiffs and large corporate defendants, the recent BMS Supreme Court decision threatens to turn back the clock. By severely limiting a plaintiffs’ choice of forum in state courts, Bristol-Myers threatens to further consolidate cases in federal MDL proceedings. For the state court option to be economically viable, the majority of our cases need to be filed in various state courts. Otherwise, those cases would automatically be subject to a substantial common benefit fee paid to the MDL attorneys and we would be deprived of adequate compensation. The ability to avoid an MDL fee incentivizes plaintiffs firms to push for and try cases in state courts, thereby creating pressure for defendants to settle. Having several different plaintiff firms litigating in various venues promotes diversity of litigation tactics thereby increasing creativity, innovation, and benefiting the litigation as a whole.

Aside from sufficient and viable state venues, it will become very difficult for a firm to again operate outside an MDL proceeding. Such heightened consolidation can be of great benefit to defendants and relieve settlement pressure. The consolidated proceeding creates a bottleneck where only a limited number of plaintiff attorneys can control and actively work on the litigation. Law firms that otherwise would have contributed their skills and knowledge in litigating state cases may now be sidelined. Completely consolidating cases in an MDL further “declaws plaintiffs … by depriving them of the weapon that pressures a defendant to pay a reasonable amount in settlement: the threat of forcing an exchange at a price set by a jury.”[2]

Having only one consolidated proceeding can also distort how different patients are treated in global settlements. The initial bellwether trials in MDLs are typically handpicked by the lead attorneys and tend to be the plaintiff with the least amount of risk factors for the injury at issue. Therefore, these bellwether plaintiffs aren’t representative of the total client pool. In our state, Actos trials tried cases that were more reflective of the client pool. Those clients included several former smokers.

Because smoking is a leading risk factor for bladder cancer, it was thought that these clients would lose at trial. By actually trying the case, we found that juries really didn’t have a problem with a smoking history. Having a past smoking history was actually helpful in some respects. Evidence showed Actos was a tumor promotor, so it made sense that another chemical had to cause some initial cellular damage that was amplified by Actos. Most jurisdictions require only that the product was a substantial contributing factor in causing cancer so we could embrace smoking history as part of the theory of our case. We even started moving for and winning summary judgment on any contributory negligence claims involving smoking. Our success at trial with past smokers paved the way for a fair settlement for these clients.

BMS leaves room for interpretation as to the role of a co-defendant’s domicile in establishing jurisdiction, so the scope of the decision will be battled out in the years to come. Hopefully, the courts will opt for a narrow reading of BMS and allow for more firms to actually innovate and litigate mass tort cases outside of MDL proceedings.


[1] DeLaventura v. Columbia Acorn Trust, 417 F. Supp. 2d 147, 150 (D. Mass. 2006).

[2] Charles Silver, Geoffrey P. Miller The Quasi-Class Action Method of Managing Multi-District Litigations: Problems and a Proposal, Vanderbilt Law Review, 63 Vand.L.Rev. 107 (2010).


Jeffrey Travers is an associate attorney focusing his practice on mass torts, pharmaceutical litigation, and products liability. Mr. Travers received his B.A. degree from the College of William and Mary and received his J.D. from Northeastern University School of Law. Prior to joining The Miller Firm in 2008, Mr. Travers gained experience in civil litigation as a law clerk for the National Whistleblower Center; Bernabei & Wachtel (an employment law firm); Northeastern University’s Office of Legal Counsel; and the U.S. Virgin Islands’ Department of Justice.

For 30 years, Michael J. Miller has been in the private practice of representing those injured and aggrieved in cases of personal injury. He received his undergraduate degree in political science from the University of Maryland in 1975. Immediately following, he pursued his legal degree from the University of Baltimore, receiving his Doctor of Jurisprudence in 1978. He was first admitted to practice law in Virginia (1979), then Washington D.C. (1985), Maryland (1986), and Pennsylvania.

Related Articles

Divide and Conquer: Plaintiffs Need a Single Forum that Accommodates the Realities of Contemporary Economic Activity

by David A. Mazie and David M. Estes

The growth of mass tort litigation tracks with industries’ shift to mass marketing and distribution of pharmaceutical and consumer products on a national scale.

Contemporary Economic Activity

The Parade of Horribles

by Amy Gunn

Lawsuits about a blood-thinning drug that prevents platelets from clumping together now prevents plaintiffs from joining together to bring state law claims against a corporation when not every plaintiff was harmed in that state.

Bristol-Myers Squibb v Superior Court of CA

Supreme Court further Restricts Where Plaintiffs Can Sue in Mass Torts

by Gregory Bubalo and Katherine A. Dunnington

Bristol-Myers Squibb Co. v. Superior Court of California will significantly impact the plaintiffs’ choices of forums for the filing of mass torts actions.

Plaintiffs No Longer Sue in Mass Torts

Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco

by Clifford J. Zatz and Josh Thomas Foust

The decision “may make it impossible to bring certain mass actions at all.”

Bristol-Myers Squibb Co. Mass Tort

Trending Articles

Announcing the 2023 The Best Lawyers in America Honorees

by Best Lawyers

Only the top 5.3% of all practicing lawyers in the U.S. were selected by their peers for inclusion in the 29th edition of The Best Lawyers in America®.

Gold strings and dots connecting to form US map

Best Lawyers: Ones to Watch in America for 2023

by Best Lawyers

The third edition of Best Lawyers: Ones to Watch in America™ highlights the legal talent of lawyers who have been in practice less than 10 years.

Three arrows made of lines and dots on blue background

Announcing the 2022 Best Lawyers® in the United States

by Best Lawyers

The results include an elite field of top lawyers listed in the 28th Edition of The Best Lawyers in America® and in the 2nd Edition of Best Lawyers: Ones to Watch in America for 2022.

2022 Best Lawyers Listings for United States

Famous Songs Unprotected by Copyright Could Mean Royalties for Some

by Michael B. Fein

A guide to navigating copyright claims on famous songs.

Can I Sing "Happy Birthday" in Public?

Announcing the 2023 The Best Lawyers in Canada Honorees

by Best Lawyers

The Best Lawyers in Canada™ is entering its 17th edition for 2023. We highlight the elite lawyers awarded this year.

Red map of Canada with white lines and dots

Choosing a Title Company: What a Seller Should Expect

by Roy D. Oppenheim

When it comes to choosing a title company, how much power exactly does a seller have?

Choosing the Title Company As Seller

What the Courts Say About Recording in the Classroom

by Christina Henagen Peer and Peter Zawadski

Students and parents are increasingly asking to use audio devices to record what's being said in the classroom. But is it legal? A recent ruling offer gives the answer to a question confusing parents and administrators alike.

Is It Legal for Students to Record Teachers?

Announcing the 2022 Best Lawyers in Canada™

by Best Lawyers

The results include an elite field of top lawyers listed in the 16th Edition of The Best Lawyers in Canada™ and 1st Edition of Best Lawyers: Ones to Watch in Canada.

Announcing the 2022 Best Lawyers in Canada™

Caffeine Overload and DUI Tests

by Daniel Taylor

While it might come as a surprise, the over-consumption of caffeine could trigger a false positive on a breathalyzer test.

Can Caffeine Cause You to Fail DUI Test?

The Real Camille: An Interview with Johnny Depp’s Lawyer Camille Vasquez

by Rebecca Blackwell

Camille Vasquez, a young lawyer at Brown Rudnick, sat down with Best Lawyers CEO Phillip Greer to talk about her distinguished career, recently being named partner and what comes next for her.

Camille Vasquez in office

Announcing the 2022 "Best Law Firms" Rankings

by Best Lawyers

The 2022 “Best Law Firms” publication includes all “Law Firm of the Year” recipients, national and metro Tier 1 ranked firms and editorial from thought leaders in the legal industry.

The 2022 Best Law Firms Awards

Wage and Overtime Laws for Truck Drivers

by Greg Mansell

For truck drivers nationwide, underpayment and overtime violations are just the beginning of a long list of problems. Below we explore the wages you are entitled to but may not be receiving.

Truck Driver Wage and Overtime Laws in the US

All Eyes to the Ones on the Rise

by Rebecca Blackwell

Our 2023 honorees recognized in Best Lawyers: Ones to Watch™ in America tell us more about how their path to law formed, what lead them to their practice areas and how they keep steadfast in their passion to serve others.

Person walking between glass walls towards window

Announcing The Best Lawyers in Australia™ 2023

by Best Lawyers

The results include an elite field of top lawyers and firms from Australia.

The Best Lawyers in Australia™ 2023

Announcing the 2022 Best Lawyers™ in Australia

by Best Lawyers

The results include an elite field of top lawyers and firms.

Announcing the 2022 Best Lawyers™ in Australi

The Key to Success? Be Prepared to Walk Away

by Sara Collin

Oatley Vigmond partner and The Best Lawyers in Canada awardee Brian M. Cameron discusses his illustrious career and techniques for trial and negotiation that have led to his success.

Man with grey hair and red tie